logo    Company Page

Most Recent Insiders Activity

Transaction Date Company Name Insider Name (Title) Activity Stock Acquired or Disposed Shares Price range Amount
2024-09-17 Kymera Therapeutics, Inc. Esposito Pamela
(Director)
S Common Stock D 13500 $47.75 - $48.75 $651,765
2024-09-17 Kymera Therapeutics, Inc. Esposito Pamela
(Director)
M Common Stock A 13500 $14.18 - $29.55 $322,075
2024-08-26 Kymera Therapeutics, Inc. Albers Jeffrey W.
(Director)
S Common Stock D 5000 $49.10 - $49.10 $245,508
2024-08-26 Kymera Therapeutics, Inc. Albers Jeffrey W.
(Director)
M Common Stock A 5000 $10.34 - $10.34 $51,700
2024-07-15 Kymera Therapeutics, Inc. Gollob Jared
(Chief Medical Officer)
S Common Stock D 39600 $45.15 - $46.10 $1,803,141
2024-07-15 Kymera Therapeutics, Inc. Gollob Jared
(Chief Medical Officer)
M Common Stock A 39600 $2.08 - $2.08 $82,367
2024-07-09 Kymera Therapeutics, Inc. Booth Bruce
(Director)
S Common Stock D 453960 $35.57 - $39.26 $17,346,913
2024-06-27 Kymera Therapeutics, Inc. Jacobs Bruce N.
(Chief Financial Officer)
M Common Stock A 25000 $2.08 - $2.08 $52,000
2024-06-18 Kymera Therapeutics, Inc. Mainolfi Nello
(Chief Executive Officer)
M Common Stock A 14413 $2.08 - $2.08 $29,979
2024-06-12 Kymera Therapeutics, Inc. Booth Bruce
(Director)
S Common Stock D 26940 $34.98 - $36.02 $950,171
2024-06-07 Kymera Therapeutics, Inc. Horobin Joanna
(Director)
S Common Stock D 8500 $32.65 - $33.11 $280,399
2024-06-07 Kymera Therapeutics, Inc. Horobin Joanna
(Director)
M Common Stock A 8500 $2.08 - $2.08 $17,680
logo   

Please upgrade to premium to see all results. Signup if you don't have an account.

Login Signup
Activity types
A Grant, award or other acquisition
C Conversion of Derivative or Security
D Disposition to the issuer of issuer equity securities
E Expiration of short derivative position
F Payment of exercise price or tax liability
G Bona fide Gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary Transaction
J Other acquisition or disposition
K Transaction in equity swap or instrument with similar characteristics
L Small Acquisition
M Exercise or conversion of derivative security
O Exercise of out-of-the-money derivative security
P Open Market Purchase
S Open Market Sale
U Disposition pursuant to a tender of shares in a change of control transaction
V Transaction Voluntarily Reported
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust
Debug Info- Version: 2.6